Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 4-60 (IGLV4-60) encodes the variable region of the lambda light chain of human immunoglobulins, which is involved in antigen recognition as part of the adaptive immune response[4][2]. This gene belongs to the immunoglobulin lambda variable family and is expressed in B lymphocytes, where its variable region contributes to the diversity of antibody specificity through V-(D)-J gene rearrangement[2][3]. IGLV4-60 is not a therapeutic target by itself, but rather a genetic segment used in the assembly of antibodies, which can be further diversified in response to antigen exposure[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 4-60 (IGLV4-60).